Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vivos Therapeutics (VVOS) Gross Profit (2020 - 2025)

Historic Gross Profit for Vivos Therapeutics (VVOS) over the last 6 years, with Q3 2025 value amounting to $3.9 million.

  • Vivos Therapeutics' Gross Profit rose 6868.04% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 712.46%. This contributed to the annual value of $9.0 million for FY2024, which is 904.36% up from last year.
  • Per Vivos Therapeutics' latest filing, its Gross Profit stood at $3.9 million for Q3 2025, which was up 6868.04% from $2.1 million recorded in Q2 2025.
  • Vivos Therapeutics' Gross Profit's 5-year high stood at $3.9 million during Q3 2025, with a 5-year trough of $1.5 million in Q1 2025.
  • Its 5-year average for Gross Profit is $2.5 million, with a median of $2.4 million in 2022.
  • Per our database at Business Quant, Vivos Therapeutics' Gross Profit crashed by 3000.8% in 2023 and then surged by 6868.04% in 2025.
  • Vivos Therapeutics' Gross Profit (Quarter) stood at $3.1 million in 2021, then dropped by 23.27% to $2.4 million in 2022, then fell by 12.37% to $2.1 million in 2023, then rose by 0.38% to $2.1 million in 2024, then surged by 87.74% to $3.9 million in 2025.
  • Its Gross Profit was $3.9 million in Q3 2025, compared to $2.1 million in Q2 2025 and $1.5 million in Q1 2025.